{"transactions":[{"id":740099,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:28:12.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":34090,"price":2.574,"value":87747.66,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and has been completely exercised."}],"balance_after":0,"derivative":{"exercise_price":2.574,"expiration_date":"2027-08-30","underlying":"Common Stock","underlying_shares":34090},"source":{"system":"sec-edgar","filing":"0001836662-26-000005","document":"wk-form4_1781296090.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666226000005/wk-form4_1781296090.xml","form_type":"4"}},{"id":740098,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-12T16:28:12.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":34090,"price":2.574,"value":87747.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,783 shares purchased on May 31, 2026 through the Company's Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the unvested portion of the Reporting Person's RSU grants."}],"balance_after":184607,"source":{"system":"sec-edgar","filing":"0001836662-26-000005","document":"wk-form4_1781296090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666226000005/wk-form4_1781296090.xml","form_type":"4"}},{"id":931218,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T20:21:34.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company."}],"balance_after":96000,"derivative":{"exercise_price":22.13,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001836662-26-000002","document":"wk-form4_1769476892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666226000002/wk-form4_1769476892.xml","form_type":"4"}},{"id":931217,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-26T20:21:34.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the unvested portion of the Reporting Person's RSU grants."}],"balance_after":148734,"source":{"system":"sec-edgar","filing":"0001836662-26-000002","document":"wk-form4_1769476892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666226000002/wk-form4_1769476892.xml","form_type":"4"}},{"id":963236,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-12-18T17:35:45.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":6810,"price":22.1595,"value":150906.195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the\ndate of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting\nperson."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes the unvested portion of the reporting person's RSU grants."}],"balance_after":124734,"source":{"system":"sec-edgar","filing":"0001836662-25-000005","document":"wk-form4_1766097342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666225000005/wk-form4_1766097342.xml","form_type":"4"}},{"id":963235,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-12-18T17:35:45.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":7658,"price":21.8843,"value":167589.9694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the\ndate of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting\nperson."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to\nthe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1 share purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes the unvested portion of the reporting person's RSU grants."}],"balance_after":131544,"source":{"system":"sec-edgar","filing":"0001836662-25-000005","document":"wk-form4_1766097342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000183666225000005/wk-form4_1766097342.xml","form_type":"4"}},{"id":1294573,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-27T16:31:03.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company."}],"balance_after":150000,"derivative":{"exercise_price":13.33,"expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001724521-25-000021","document":"wk-form4_1738013456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452125000021/wk-form4_1738013456.xml","form_type":"4"}},{"id":1294572,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-27T16:31:03.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company."}],"balance_after":137623,"source":{"system":"sec-edgar","filing":"0001724521-25-000021","document":"wk-form4_1738013456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452125000021/wk-form4_1738013456.xml","form_type":"4"}},{"id":1328999,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-12-17T20:36:51.000Z","date":"2024-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11339,"price":16.08,"value":182331.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":100623,"source":{"system":"sec-edgar","filing":"0001724521-24-000183","document":"wk-form4_1734485805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452124000183/wk-form4_1734485805.xml","form_type":"4"}},{"id":1475544,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-06-18T16:53:54.000Z","date":"2024-06-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4182,"price":16.97,"value":70968.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 967 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan."}],"balance_after":111364,"source":{"system":"sec-edgar","filing":"0001724521-24-000126","document":"wk-form4_1718744028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452124000126/wk-form4_1718744028.xml","form_type":"4"}},{"id":1671055,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T19:39:38.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":108200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":108200,"derivative":{"exercise_price":15.44,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":108200},"source":{"system":"sec-edgar","filing":"0001724521-24-000027","document":"wk-form4_1706229568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452124000027/wk-form4_1706229568.xml","form_type":"4"}},{"id":1671054,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-01-25T19:39:38.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":114579,"source":{"system":"sec-edgar","filing":"0001724521-24-000027","document":"wk-form4_1706229568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452124000027/wk-form4_1706229568.xml","form_type":"4"}},{"id":1703442,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-12-20T16:10:52.000Z","date":"2023-12-19","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":4076,"price":18.09,"value":73734.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.78 to $18.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":87879,"source":{"system":"sec-edgar","filing":"0001724521-23-000070","document":"wk-form4_1703106643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452123000070/wk-form4_1703106643.xml","form_type":"4"}},{"id":1703441,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-12-20T16:10:52.000Z","date":"2023-12-18","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":3991,"price":17.74,"value":70800.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.45 to $17.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 44 shares purchased on 11/30/2023 through the Company's Employee Stock Purchase Plan."}],"balance_after":91955,"source":{"system":"sec-edgar","filing":"0001724521-23-000070","document":"wk-form4_1703106643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000172452123000070/wk-form4_1703106643.xml","form_type":"4"}},{"id":1852551,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-06-16T20:17:56.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":2892,"price":19.35,"value":55960.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,255 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan."}],"balance_after":95902,"source":{"system":"sec-edgar","filing":"0001209191-23-038160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919123038160/doc4.xml","form_type":"4"}},{"id":2046533,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-25T17:52:48.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":138200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":138200,"derivative":{"exercise_price":22.02,"expiration_date":"2033-01-22","underlying":"Common Stock","underlying_shares":138200},"source":{"system":"sec-edgar","filing":"0001209191-23-004874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919123004874/doc4.xml","form_type":"4"}},{"id":2046532,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-01-25T17:52:48.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":97539,"source":{"system":"sec-edgar","filing":"0001209191-23-004874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919123004874/doc4.xml","form_type":"4"}},{"id":2083932,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-12-16T21:42:53.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":398,"price":31.23,"value":12429.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $31.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":28584,"source":{"system":"sec-edgar","filing":"0001209191-22-061761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122061761/doc4.xml","form_type":"4"}},{"id":2083931,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-12-16T21:42:53.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":2125,"price":30.66,"value":65152.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $31.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":28982,"source":{"system":"sec-edgar","filing":"0001209191-22-061761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122061761/doc4.xml","form_type":"4"}},{"id":2225664,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T16:23:10.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":1073,"price":22.29,"value":23917.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.14 to $22.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":23909,"source":{"system":"sec-edgar","filing":"0001209191-22-038399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122038399/doc4.xml","form_type":"4"}},{"id":2225663,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T16:23:10.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":449,"price":21.71,"value":9747.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.14 to $22.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":24982,"source":{"system":"sec-edgar","filing":"0001209191-22-038399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122038399/doc4.xml","form_type":"4"}},{"id":2225662,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-06-21T16:23:10.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":1400,"price":20.72,"value":29008.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.33 to $21.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,017 shares purchased on 5/31/2022 through the Company's Employee Stock Purchase Plan"}],"balance_after":25431,"source":{"system":"sec-edgar","filing":"0001209191-22-038399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122038399/doc4.xml","form_type":"4"}},{"id":2340044,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-10T17:09:44.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in 48 equal monthly installments after January 1, 2022, subject to the Reporting Person's continued service to the Company."}],"balance_after":65000,"derivative":{"exercise_price":33.03,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-017989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122017989/doc4.xml","form_type":"4"}},{"id":2340043,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-10T17:09:44.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2022, subject to the Reporting Person's continued service to the Company."}],"balance_after":33814,"source":{"system":"sec-edgar","filing":"0001209191-22-017989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919122017989/doc4.xml","form_type":"4"}},{"id":2464106,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":225,"price":41.4238,"value":9320.355,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.10 to $41.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17564,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2464105,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":171,"price":40.5732,"value":6938.0172,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.10 to $41.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17789,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2464104,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":88,"price":39.6719,"value":3491.1272,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.10 to $40.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":17960,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2464103,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":138,"price":38.7877,"value":5352.7026,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.10 to $39.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":18048,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2464102,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-16","kind":"sale","acquired":false,"shares":131,"price":40.4565,"value":5299.8015,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.12 to $40.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":18186,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2464101,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-20T16:26:04.000Z","date":"2021-12-16","kind":"sale","acquired":false,"shares":356,"price":39.5916,"value":14094.6096,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.11 to $40.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 176 shares purchased on 11/30/2021 through the Company's Employee Stock Purchase Plan"}],"balance_after":18317,"source":{"system":"sec-edgar","filing":"0001209191-21-070568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121070568/doc4.xml","form_type":"4"}},{"id":2661494,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T16:54:26.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":1606,"price":23.68,"value":38030.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.395 to $24.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":15362,"source":{"system":"sec-edgar","filing":"0001209191-21-042082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121042082/doc4.xml","form_type":"4"}},{"id":2661493,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T16:54:26.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":52,"price":24.77,"value":1288.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.63 to $24.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":16968,"source":{"system":"sec-edgar","filing":"0001209191-21-042082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121042082/doc4.xml","form_type":"4"}},{"id":2661492,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T16:54:26.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":1257,"price":24.13,"value":30331.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.61 to $24.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,679 shares purchased on 5/28/2021 through the Company's Employee Stock Purchase Plan"}],"balance_after":17020,"source":{"system":"sec-edgar","filing":"0001209191-21-042082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121042082/doc4.xml","form_type":"4"}},{"id":2902598,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-20T16:16:02.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":75225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in 48 equal monthly installments after January 1, 2021, subject to the Reporting Person's continued service to the Company."}],"balance_after":75225,"derivative":{"exercise_price":36.73,"expiration_date":"2031-01-18","underlying":"Common Stock","underlying_shares":75225},"source":{"system":"sec-edgar","filing":"0001209191-21-004280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121004280/doc4.xml","form_type":"4"}},{"id":2902597,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38803,"kind":"person","name":"Tang Carolyn C.","position":1,"cik":"0001836662","reported_name":"Tang Carolyn C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-01-20T16:16:02.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":12538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments after January 1, 2021, subject to the Reporting Person's continued service to the Company."}],"balance_after":19886,"source":{"system":"sec-edgar","filing":"0001209191-21-004280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836662/000120919121004280/doc4.xml","form_type":"4"}}]}